Literature DB >> 14176974

PRIMARY SCLEROSING CHOLANGITIS OF THE EXTRAHEPATIC BILE DUCTS.

I B HOLUBITSKY, A D MCKENZIE.   

Abstract

Keywords:  CHOLANGITIS; COLITIS, ULCERATIVE; DRUG THERAPY; HEPATOMEGALY; STEROIDS; SURGERY, OPERATIVE

Mesh:

Substances:

Year:  1964        PMID: 14176974

Source DB:  PubMed          Journal:  Can J Surg        ISSN: 0008-428X            Impact factor:   2.089


× No keyword cloud information.
  14 in total

1.  Cancer of the bile ducts associated with ulcerative colitis.

Authors:  O E Akwari; J A Van Heerden; W T Foulk; A H Baggenstoss
Journal:  Ann Surg       Date:  1975-03       Impact factor: 12.969

2.  An unusual cholangitis.

Authors: 
Journal:  Br Med J       Date:  1976-11-06

3.  Tumors of biliary epithelium and ulcerative colitis.

Authors:  J M Ham
Journal:  Ann Surg       Date:  1968-12       Impact factor: 12.969

4.  [Four cases of primary sklerosing cholangitis].

Authors:  A Sapkas; N Karavas
Journal:  Langenbecks Arch Chir       Date:  1969

5.  [The clinical picture of primary fibrous bile duct stenosis].

Authors:  E Kern; K Beck; L Bianchi; H H Gruenagel; I Strauss; R Zwirner
Journal:  Langenbecks Arch Chir       Date:  1968

6.  Primary sclerosing cholangitis. A report of two cases.

Authors:  I H Koven; A Golab; D R Bohnen; H A Himel
Journal:  Can Med Assoc J       Date:  1969-07-26       Impact factor: 8.262

7.  A case of primary sclerosing cholangitis.

Authors:  H Shiraoku; M Hokamura; K Sagara; S Fujiyama
Journal:  Gastroenterol Jpn       Date:  1985-08

8.  Primary sclerosing cholangitis: results of an aggressive surgical approach.

Authors:  H A Pitt; H H Thompson; R K Tompkins; W P Longmire
Journal:  Ann Surg       Date:  1982-09       Impact factor: 12.969

Review 9.  Primary sclerosing cholangitis.

Authors:  L Tinckler
Journal:  Postgrad Med J       Date:  1971-10       Impact factor: 2.401

10.  Primary sclerosing cholangitis: a heterogenous disease.

Authors:  H H Thompson; H A Pitt; R K Tompkins; W P Longmire
Journal:  Ann Surg       Date:  1982-08       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.